Cardiome Pharma Corporation is the product focused cardiovascular drug developing enterprise with twin clinical drug programs focused on arterial arrhythmia – intravenous and oral dosing as well as the pre-clinical program intended for increasing cardiovascular activities.
The intravenous formulation of Vernakalant is the new untried drug which is under assessment for the sharp adaptation of arterial fibrillation – AF. Positive top-line conclusions from the two essential phase 3 ...
| Currently you cannot purchase Vernackalant as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Vernackalant |
| Vernackalant Availability Subscription Form |
|
| |
| Note: We will email you when Vernackalant is available for sale online or in pharmacy in your country. |
|
|
|